Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Chromatics Color Sciences International. Inc; CCSI -- Ignore unavailable to you. Want to Upgrade?

To: JanyBlueEyes who wrote (3308)	6/22/1998 4:21:00 PM
From: HedyVP	Read Replies (2) \| Respond to of 5736

Gt. News ,,,,,while the scumbags were busy to run the stock down, Darby was busy making deals,,,, These "fine" lawyers are still scrounging around to find a lead plaintiff, what a waste of time for any company to have to spend time and money for a defense of their co. The shorts create the carnage, then the vultures move in and sue. What a combo they are !!

To: JanyBlueEyes who wrote (3308)	6/22/1998 10:56:00 PM
From: JanyBlueEyes	Respond to of 5736

Kernicterus in term infants - China ---------- Kernicterus: Disorder due to jaundice in a newborn baby with high blood levels of the pigment bilirubin that is deposited in the brain resulting in damage. The level of bilirubin is monitored in newborns to determine whether treatment is needed to prevent kernicterus. With brain affected, it is also called bilirubin encephalopathy ---------- Aust Paediatr J 1985 Nov;21(4):273-274 Yeung CY ncbi.nlm.nih.gov Kernicterus is a frequent occurrence in Chinese term infants. In a previous study, the mean level of serum bilirubin of 152 kernicteric infants was 35.4 mg/dl (605.3 mumol/l) and the range was 22.3-50 mg/dl. More recently, three further term infants developed kernicterus and one exhibited bilirubin level of only 23.3 mg/dl. Features of haemolysis were lacking in 56.8% of these infants. Evidence of brain damage occurred in 26.5% in a former series and in 5.5% of the more recent study of those infants who developed bilirubinaemia exceeding 20 mg/dl. Such a high risk favours the present practice of exchange transfusion for rising bilirubin beyond 20 mg/dl (342 mumol/l) in Chinese term infants. PMID: 3867347, UI: 86130280